The discovery of nitric oxide (NO) as an endogenously generated signaling species in mammalian cells has spawned a vast interest in the study of the chemical biology of nitrogen oxides. Of these, nitroxyl (azanone, HNO) has gained much attention for its potential role as a therapeutic for cardiovascular disease. Known targets of HNO include hemes/heme proteins and thiols/thiol-containing proteins. Recently, due to their roles in redox signaling and cellular defense, selenols and selenoproteins have also been speculated to be additional potential targets of HNO. Indeed, as determined in the current work, selenols are targeted by HNO. Such reactions appear to result only in formation of diselenide products, which can be easily reverted back to the free selenol. This characteristic is distinct from the reaction of HNO with thiols/thiolproteins. These findings suggest that, unlike thiolproteins, selenoproteins are resistant to irreversible oxidative modification, indicating that Nature may have chosen to use selenium, instead of sulfur, in certain biological systems for this reason.
Introduction
Nitroxyl (HNO) is the one electron reduced and protonated congener of nitric oxide (NO). Like NO, HNO has gained much interest for its effects on the cardiovascular system, especially for its potential as a therapeutic agent to treat heart failure. [1] [2] [3] [4] Importantly, the reactivity of HNO is distinct from that of NO. For example, HNO does not have an unpaired electron and is therefore not expected to react with radical species via direct radical-radical interactions. Additionally, NO and HNO are both known to react with heme-containing proteins; however, NO preferentially favors ferrous hemes whereas HNO favors ferric hemes. 5 Other targets of HNO, which are of more relevance to the current study, are thiols and thiol-containing proteins. 6, 7 In general, HNO-induced modification of thiols follows two primary pathways (Scheme 1), ultimately leading to the corresponding disulfide (RSSR') and/or sulfinamide (RS(O)NH 2 ). [8] [9] [10] The initial reaction of HNO with a thiol results in an Nhydroxysulfenamide intermediate (RSNHOH). 8, 9 In the presence of excess thiol (RSH), the N-hydroxysulfenamide reacts with a second equivalent of thiol to form the corresponding disulfide 8, 9 (Scheme 1, Pathway A). Alternatively, if thiol concentrations are limited, the N-hydroxysulfenamide undergoes rearrangement to the corresponding sulfinamide [8] [9] [10] [11] [12] [13] (Scheme 1, Pathway B). Thiol modification to a disulfide is considered to be biologically reversible as disulfides are readily reduced in the presence of biological reductants. 8, 9 However, thiol modification to the sulfinamide has been traditionally considered to be irreversible, though recent studies have shown that reduction of the sulfinamide is possible, albeit slow.
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Scheme 1: Pathways for the reaction of HNO with thiols Like thiols, selenols are also biologically relevant species with critical roles in redox signaling. Regarded as the 21 st amino acid, selenocysteine (Sec) is the seleniumcontaining analogue of cysteine (Cys). 18 Currently, three main classes of enzymes have been identified that contain selenocysteine within the active site. These enzymes include the glutathione peroxidases (GPx), thioredoxin reductases (TrxR), and iodothyronine deiodinases (DIO). 19 Each of these enzyme classes relies on a selenocysteine residue for catalysis, most of which involve antioxidant functions. For example, GPx catalyzes the reduction of hydrogen peroxide and alkylhydroperoxides. 20 TrxR is the only known enzyme to reduce oxidized thioredoxin (Trx), which has a number of significant roles in redox signaling. 21 DIO catalyzes the deiodination of the inactive thyroid hormone, T 4 , to the active hormone, T 3 , which has been reported to have roles in cardiovascular function and metabolism.
Compared with thiols, selenols have enhanced nucleophilicity and reducing capabilities. 22, 23 For example, Sec has a pK a of 5.2 and a reduction potential (selenocystine (Sec 2 )/Sec) of -0.386 V (vs. Ag/AgCl, pH 7), while Cys has a pK a of 8.5
and a reduction potential (cystine (Cys 2 )/Cys) of -0.223 V under analogous conditions. 18, 22, 23 Likewise, the quantification of free selenol species can be determined with use of DTNB, which also liberates TNB upon reaction with free selenols. To quantify free selenol concentrations, quartz cuvettes containing 3 mL of 100 mM phosphate buffer (pH 7. Aliquots (60 µL) of headspace from all vials were analyzed for N 2 O production via gas chromatography (GC). [36] [37] [38] [39] As controls, incubations for PhSeH and PhSH were also carried out with the AS byproduct, nitrite (NO 2 -), under the same conditions. Free selenol or thiol concentration was also quantified by DTNB analysis post incubation for all reaction mixtures and controls. Aliquots of each mixture were analyzed by HPLC (Waters HPLC system equipped with a Delta 600 pump system and a dual-wavelength absorbance detector) on an Apollo C 18 reverse phase column using an isocratic gradient of 85 % methanol with 0.1 % trifluoroacetic acid (TFA) at 40 °C. Samples containing PhSeH and onitrophenylselenol (o-NPS) were followed at 254 nm. Samples containing Lselenocysteine (SecOMe) were followed at 220 nm. All peaks were assigned by comparison with authentic samples. It should be noted that at pH 7.4, PhSeH (pK a = 5.9) is mostly deprotonated, whereas PhSH (pK a = 6.6) is less so. Thus, the overall increase in the observed reactivity of PhSeH vs. PhSH with HNO is partially due to the greater amount of anion present under the experimental conditions (pH 7.4). Since the selenolate and thiolate are expected to be much more reactive than the corresponding selenol and thiol, an environment that regulates the protonation state of these species (i.e., proteins) would be expected to influence the relative reactivity of selenols and thiols. 
NMR analysis of selenol incubations with 2-

Detection of HNO-derived products via ESI-MS.
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were then performed for the reaction pathways leading from the reactions of PhSeH (1) with HNO (Scheme 3).
Scheme 3:
Proposed pathways leading from the reaction of PhSeH (1) Reaction Progress . GSH thereby acts to resolve hydroperoxide-induced oxidation of the GPx-selenol and prevents its overoxidation to seleninic and/or selenonic acid species. It should be noted that in addition to the previously described catalytic mechanism, some have considered that in the presence of excess hydroperoxide, the selenenic acid intermediate can be overoxidized to the seleninic acid (GPx-Se(O)OH, Eq 4), thus reducing enzymatic activity. 53 However to date, overoxidation of the selenenic acid has yet to be observed in an in vivo setting and therefore, may prove to be an irrelevant or inaccessible biological modification of selenols and selenoproteins.
This behavior of GPx is similar to that observed in the current study of organoselenols. Upon treatment of selenols with HNO, the initial reaction is thought to result in an N-hydroxyselenenamide intermediate. Rearrangement of this species to a seleninamide is presumed to be an irreversible modification of the selenol species.
Instead, all evidence indicates that the N-hydroxyselenenamide intermediate is more succeptible to nucleophilic attack by a second equivalent of selenol rather than rearrangement, thus preventing it from being overoxidized. Such findings are in accordance with previously observed behaviors of selenoproteins in biological systems.
Combination of this work with that of previous work regarding seleno-compounds, suggests that Nature may choose to use selenium because it has an inherent resistance towards overoxidation/irreversible modification. This ability allows it to maintain its function in biological systems to act as a cell's major line of defense against unwanted overoxidation, even during times of oxidative stress.
Conclusion
The current work confirms that selenols are a viable target of HNO. Under similar conditions, comparison of the reactivity of thiol species versus analogous selenols indicates that selenols are a more potent trap for HNO. Previously, it has been determined that reactions involving thiols and HNO result in both reversible and HNO and yet are difficult to modify irreversibly by these same oxidants may represent the true utility of selenium and selenoproteins. However, this is speculative at this time and will require further study before such an idea can be confirmed.
